Close this search box.
Close this search box.

February 18, 2021

The pandemic gave us truly global engagement

The pandemic shut down travel but flung open the doors to a new global approach in life science virtual engagement.
global virtual engagement

When life science organizations abruptly shifted meetings and events to virtual settings in early 2020, Within3 experienced a surge in demand. This didn’t come as a surprise, but we noticed something interesting: a significant uptick in global virtual engagements run on our asynchronous platform. Suddenly, clients were eager to expand their virtual conference tables to include advisors from all over the world.

The explanation for this is simple – when anyone, anywhere can attend a meeting, life science teams can include KOLs from every part of the globe, including those who are usually too busy, prefer not to travel, tend to remain quiet in face-to-face settings, or rising stars who might not be included on a budget-constrained guest list.

Beyond simply including new voices, life science teams are building value by including global perspectives. Here are some of the key things we learned – along with our clients – about what’s possible with a more global perspective.

Diverse points of view for volume, value, and variety

One pharmaceutical client recently opened an advisory board on mental illness to academic researchers, along with the usual panel of practicing psychiatrists. In part due to the academics’ natural familiarity with asynchronous collaboration, the conversation exploded – in a good way. The research-based perspective produced a richer discussion than the client anticipated, with higher-than-usual response rates and multiple references to current research and publications.

In-person environments don’t always produce this result, because team leaders are limited in how many or what type of experts they can include in face-to-face meetings. Based on logistics and budgets, it’s often easier to include fewer viewpoints, even at the risk of missing out on valuable input.

Focus on results, not logistics

Many Within3 clients have learned that instead of asking how many people they can afford to invite to an advisory board or other virtual engagement, they can instead ask how many people they need to provide insight, meet goals, and get a holistic overview of their program.

Teams that are freed from logistical restrictions experience significant differences in the type of insights they receive. Think of the last time you tried to get a consensus on what movie to stream – if it’s a solo night in, you only have one opinion to contend with. But you’re also only drawing from your own knowledge of what’s available or might be interesting to watch. When the whole family is involved, you’ll get different opinions and many suggestions you wouldn’t have thought of on your own.

The same goes for getting insight on proposed clinical trial protocols or patient education materials. When you’re freed from the weight of logistics like hotel contracts, travel availability, and snug budgets, you open the door to a host of new insights and a new vision of what’s possible for your project.

Move at the speed of information

The pace of work in life science companies – across job functions, regions, and lines of business – is accelerating. If artificial intelligence and machine learning are shortening drug development timelines in the lab, how can other teams speed up to match that pace?

Within3 clients have cut through logistical red tape to achieve some remarkable efficiency gains: They’ve completed lead-up planning for advisory boards in four weeks instead of four months. They’ve trimmed nearly a year from rare disease guideline development with stakeholders in more than two dozen countries. And when new scientific information or clinical data is available, they can convene contracted KOLs in a matter of days – accelerating the pace at which relevant information can have an impact on critical projects.

Get the global picture

With patient-centricity emerging as a top priority in the life science industry, clinical teams need a way to reach patients virtually in a timely and efficient manner, while overcoming communication challenges in all global regions. Adding more data points to sample sizes can transform what medical affairs, clinical, or commercial teams believe to be true, and positively impact patient outcomes. And while it may seem counterintuitive, virtual engagement can actually feel more human, because all of the humans participating are on equal footing. In a virtual setting – particularly one where the questions are private or identities are hidden – all input is perceived as having equal value.

When a virtual advisory board or other online engagements are well-planned, intentionally designed, and inclusive, they generate higher-quality insights. And while COVID-19 temporarily paused our ability to interact face-to-face, it also ushered in an era of global collaboration and the ability for life science teams to make decisions based on an expanded viewpoint.

To learn more about how Within3 connects stakeholders for more informed perspectives, read a customer success story.

Related Posts:

amplify patient voices

Amplifying patient voices in pharma

Event recap: AdvaMed Accel Leadership Seminar

commercial success in pharma

3 ways pharma teams can create opportunities for commercial success

More insights, direct to your inbox.